|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
US7589180B2
(en)
|
2001-05-11 |
2009-09-15 |
Abbott Laboratories Inc. |
Specific binding proteins and uses thereof
|
|
US8088387B2
(en)
*
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
US7276497B2
(en)
*
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
JP5149620B2
(ja)
|
2004-07-23 |
2013-02-20 |
エンドサイト，インコーポレイテッド |
２価リンカーおよびその結合体
|
|
US20110166319A1
(en)
*
|
2005-02-11 |
2011-07-07 |
Immunogen, Inc. |
Process for preparing purified drug conjugates
|
|
EP3539572A1
(en)
|
2005-08-24 |
2019-09-18 |
ImmunoGen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
|
EP2126127B1
(en)
|
2007-01-25 |
2016-09-28 |
Dana-Farber Cancer Institute, Inc. |
Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
|
|
CA2680854C
(en)
|
2007-03-15 |
2017-02-14 |
Ludwig Institute For Cancer Research |
Treatment method using egfr antibodies and src inhibitors and related formulations
|
|
BRPI0809435A2
(pt)
|
2007-03-27 |
2014-09-09 |
Sea Lane Biotechnologies, Llc |
Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos
|
|
US8895610B1
(en)
|
2007-05-18 |
2014-11-25 |
Heldi Kay |
Platinum (IV) compounds targeting zinc finger domains
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
CN104383553A
(zh)
|
2007-06-25 |
2015-03-04 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
US9283276B2
(en)
|
2007-08-14 |
2016-03-15 |
Ludwig Institute For Cancer Research Ltd. |
Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
|
|
US9345739B2
(en)
*
|
2007-11-08 |
2016-05-24 |
The General Hospital Corporation |
Methods and compositions for the treatment of proteinuric diseases
|
|
EP2281006B1
(en)
|
2008-04-30 |
2017-08-02 |
Immunogen, Inc. |
Cross-linkers and their uses
|
|
MX2011004625A
(es)
|
2008-11-03 |
2011-07-20 |
Syntarga Bv |
Analogos cc-1065 novedosos y sus conjugados.
|
|
UY32560A
(es)
|
2009-04-29 |
2010-11-30 |
Bayer Schering Pharma Ag |
Inmunoconjugados de antimesotelina y usos de los mismos
|
|
JP2012526839A
(ja)
|
2009-05-13 |
2012-11-01 |
シー レーン バイオテクノロジーズ， エルエルシー |
インフルエンザウイルスに対する中和分子
|
|
EP2437790B1
(en)
|
2009-06-03 |
2019-02-20 |
Immunogen, Inc. |
Conjugation methods
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
US9173961B2
(en)
|
2010-02-10 |
2015-11-03 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
|
AR080301A1
(es)
|
2010-02-24 |
2012-03-28 |
Immunogen Inc |
Anticuerpos e inmunoconjugados del receptor 1 de folato y sus usos
|
|
MX338932B
(es)
|
2010-03-12 |
2016-05-06 |
Immunogen Inc |
Moleculas de union cd37 y sus inmunoconjugados.
|
|
WO2011130598A1
(en)
*
|
2010-04-15 |
2011-10-20 |
Spirogen Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2742216T3
(es)
|
2010-04-15 |
2020-02-13 |
Kodiak Sciences Inc |
Polímeros que contienen zwitteriones de alto peso molecular
|
|
CA2956934C
(en)
|
2010-04-21 |
2019-07-09 |
Syntarga B.V. |
Novel conjugates of cc-1065 analogs and bifunctional linkers
|
|
FR2963007B1
(fr)
|
2010-07-26 |
2013-04-05 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application therapeutique
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
WO2012027745A1
(en)
*
|
2010-08-27 |
2012-03-01 |
University Of Miami |
Treatment of renal diseases
|
|
KR20140008308A
(ko)
|
2010-10-29 |
2014-01-21 |
이뮤노젠 아이엔씨 |
신규한 egfr-결합 분자 및 이의 면역컨쥬게이트
|
|
CN103328505B
(zh)
|
2010-10-29 |
2015-12-02 |
伊缪诺金公司 |
非拮抗性egfr结合分子及其免疫偶联物
|
|
CN107011253B
(zh)
*
|
2010-12-09 |
2021-01-15 |
伊缪诺金公司 |
制备带电荷交联剂的方法
|
|
KR20140010076A
(ko)
|
2011-02-15 |
2014-01-23 |
이뮤노젠 아이엔씨 |
세포독성 벤조다이아제핀 유도체
|
|
WO2012135517A2
(en)
|
2011-03-29 |
2012-10-04 |
Immunogen, Inc. |
Preparation of maytansinoid antibody conjugates by a one-step process
|
|
TR201902180T4
(tr)
|
2011-03-29 |
2019-03-21 |
Immunogen Inc |
Tek adimli bi̇r i̇şlem i̇le maytansi̇noi̇d anti̇kor konjugatlarinin hazirlanmasi
|
|
PL2694106T3
(pl)
|
2011-04-01 |
2018-06-29 |
Immunogen, Inc. |
Sposoby zwiększania skuteczności terapii przeciwnowotworowej opartej na receptorze folr1
|
|
CN105999293B
(zh)
|
2011-04-01 |
2019-07-23 |
德彪发姆国际有限公司 |
Cd37结合分子及其免疫缀合物
|
|
US20120282282A1
(en)
*
|
2011-04-04 |
2012-11-08 |
Immunogen, Inc. |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
|
|
MX350954B
(es)
|
2011-06-21 |
2017-09-26 |
Immunogen Inc |
Derivados de maitansinoides novedosos con enlazador de peptido y conjugados de estos.
|
|
EP2736928B1
(en)
|
2011-07-28 |
2019-01-09 |
i2 Pharmaceuticals, Inc. |
Sur-binding proteins against erbb3
|
|
ES2806146T3
(es)
|
2011-09-22 |
2021-02-16 |
Amgen Inc |
Proteínas de unión al antígeno CD27L
|
|
PT2750713E
(pt)
*
|
2011-10-14 |
2016-01-20 |
Genentech Inc |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
KR20140105765A
(ko)
|
2011-11-21 |
2014-09-02 |
이뮤노젠 아이엔씨 |
EGfr 항체 세포독성제 접합체에 의한 EGfr 치료에 내성을 나타내는 종양의 치료 방법
|
|
EP2793940B1
(en)
|
2011-12-22 |
2018-11-14 |
i2 Pharmaceuticals, Inc. |
Surrogate binding proteins
|
|
HK1204445A1
(en)
|
2012-01-20 |
2015-11-20 |
Sea Lane Biotechnologies, Llc |
Surrobody cojugates
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
AU2013263002C1
(en)
|
2012-05-15 |
2018-05-31 |
Seagen Inc. |
Self-stabilizing linker conjugates
|
|
AR091069A1
(es)
|
2012-05-18 |
2014-12-30 |
Amgen Inc |
Proteinas de union a antigeno dirigidas contra el receptor st2
|
|
SG10201610869TA
(en)
|
2012-06-26 |
2017-02-27 |
Del Mar Pharmaceuticals |
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalacti
|
|
KR20150046316A
(ko)
|
2012-08-31 |
2015-04-29 |
이뮤노젠 아이엔씨 |
엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
|
|
WO2014055842A1
(en)
*
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
RU2661083C2
(ru)
*
|
2012-10-04 |
2018-07-11 |
Иммуноджен, Инк. |
Использование пвдф-мембраны для очистки конъюгатов клеточно-связывающий агент - цитотоксический агент
|
|
WO2014057687A1
(ja)
|
2012-10-11 |
2014-04-17 |
第一三共株式会社 |
抗体－薬物コンジュゲート
|
|
ES2738310T3
(es)
|
2012-10-12 |
2020-01-21 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
WO2014061277A1
(ja)
|
2012-10-19 |
2014-04-24 |
第一三共株式会社 |
親水性構造を含むリンカーで結合させた抗体－薬物コンジュゲート
|
|
WO2014070957A1
(en)
*
|
2012-10-30 |
2014-05-08 |
Esperance Pharmaceuticals, Inc. |
Antibody/drug conjugates and methods of use
|
|
HRP20170743T1
(hr)
|
2012-11-20 |
2017-07-28 |
Sanofi |
Anti-ceacam5 protutijela i njihova uporaba
|
|
AU2012395148B2
(en)
|
2012-11-24 |
2016-10-27 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Ｂｃｍａ抗原結合蛋白質
|
|
EP2948478B1
(en)
|
2013-01-25 |
2019-04-03 |
Amgen Inc. |
Antibodies targeting cdh19 for melanoma
|
|
WO2014134457A2
(en)
*
|
2013-02-28 |
2014-09-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
HK1219422A1
(zh)
|
2013-02-28 |
2017-04-07 |
Immunogen, Inc. |
包含细胞结合剂及细胞毒素剂的轭合物
|
|
EP2961435B1
(en)
|
2013-02-28 |
2019-05-01 |
ImmunoGen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
US9415118B2
(en)
*
|
2013-03-13 |
2016-08-16 |
Novartis Ag |
Antibody drug conjugates
|
|
AU2014244245C1
(en)
|
2013-03-13 |
2018-04-19 |
Genentech, Inc. |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN105142674B
(zh)
|
2013-03-13 |
2018-11-13 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
US9498532B2
(en)
*
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
|
EP3964237B1
(en)
|
2013-03-15 |
2026-02-18 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecules, conjugates thereof, and therapeutic uses
|
|
BR112015021134A2
(pt)
|
2013-03-15 |
2017-10-10 |
Novartis Ag |
conjugados de fármaco e anticorpo
|
|
US9522876B2
(en)
|
2013-03-15 |
2016-12-20 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
EP2983674A4
(en)
|
2013-04-08 |
2017-05-10 |
Dennis M. Brown |
Therapeutic benefit of suboptimally administered chemical compounds
|
|
SG11201508829QA
(en)
|
2013-05-30 |
2015-12-30 |
Biogen Ma Inc |
Oncostatin m receptor antigen binding proteins
|
|
WO2014194030A2
(en)
|
2013-05-31 |
2014-12-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
CA2928568A1
(en)
|
2013-07-26 |
2015-01-29 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
|
PT3038650T
(pt)
|
2013-08-30 |
2021-08-25 |
Immunogen Inc |
Anticorpos e ensaios para a deteção do recetor de folato 1
|
|
SG10201801779XA
(en)
|
2013-09-05 |
2018-04-27 |
Jackson Lab |
Compositions for rna-chromatin interaction analysis and uses thereof
|
|
NZ757964A
(en)
|
2013-10-08 |
2022-07-01 |
Immunogen Inc |
Anti-folr1 immunoconjugate dosing regimens
|
|
TWI541022B
(zh)
*
|
2013-12-18 |
2016-07-11 |
應克隆公司 |
針對纖維母細胞生長因子受體－３（ｆｇｆｒ３）之化合物及治療方法
|
|
CA2934617A1
(en)
*
|
2013-12-23 |
2015-07-02 |
Bayer Pharma Aktiengesellschaft |
Antibody drug conjugates (adcs) with kinesin spindle protein (ksp)
|
|
PT3088419T
(pt)
|
2013-12-25 |
2019-01-11 |
Daiichi Sankyo Co Ltd |
Conjugado de anticorpo anti-trop2-fármaco
|
|
ES2916722T3
(es)
|
2013-12-27 |
2022-07-05 |
Zymeworks Inc |
Sistemas de enlace que contienen sulfonamida para conjugados de fármacos
|
|
AU2015205574B2
(en)
|
2014-01-10 |
2019-08-15 |
Byondis B.V. |
Method for purifying Cys-linked antibody-drug conjugates
|
|
HRP20190431T1
(hr)
|
2014-01-31 |
2019-04-19 |
Daiichi Sankyo Company, Limited |
Anti-her2 antitijelo-lijek konjugat
|
|
FI3122757T3
(fi)
*
|
2014-02-28 |
2023-10-10 |
Hangzhou Dac Biotech Co Ltd |
Varautuneita linkkereitä ja niiden konjugointikäyttötapoja
|
|
CN111228511B
(zh)
|
2014-04-10 |
2024-06-18 |
第一三共株式会社 |
抗her3抗体-药物偶联物
|
|
ES2754348T3
(es)
|
2014-04-10 |
2020-04-17 |
Daiichi Sankyo Co Ltd |
Conjugado de (anticuerpo anti-HER2)-fármaco
|
|
EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
PE20170903A1
(es)
|
2014-08-12 |
2017-07-12 |
Novartis Ag |
Conjugados de farmacos con anticuerpos anti-cdh6
|
|
AU2015311951B2
(en)
|
2014-09-02 |
2021-04-08 |
Immunogen, Inc. |
Methods for formulating antibody drug conjugate compositions
|
|
TW201613930A
(en)
|
2014-09-03 |
2016-04-16 |
Immunogen Inc |
Cytotoxic benzodiazepine derivatives
|
|
PT3189056T
(pt)
|
2014-09-03 |
2020-09-04 |
Immunogen Inc |
Derivados citotóxicos de benzodiazepina
|
|
HRP20241124T1
(hr)
|
2014-09-11 |
2024-11-22 |
Seagen Inc. |
Ciljana isporuka lijekovitih tvari koje sadrže tercijarni amin
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3194421B1
(en)
|
2014-09-17 |
2021-11-03 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
PE20170912A1
(es)
|
2014-11-14 |
2017-07-12 |
Novartis Ag |
Conjugados de anticuerpo-farmaco
|
|
US10335495B2
(en)
|
2014-12-04 |
2019-07-02 |
Celgene Corporation |
Biomolecule conjugates
|
|
CN113876962A
(zh)
|
2015-04-07 |
2022-01-04 |
纪念斯隆-凯特琳癌症中心 |
纳米粒子免疫偶联物
|
|
EP3297676A2
(en)
|
2015-05-22 |
2018-03-28 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Combination of trpm8-agonist and nachr-agonist for treatment of obesity and related disorders and for weight reduction
|
|
TW201711702A
(zh)
|
2015-06-04 |
2017-04-01 |
應克隆公司 |
使用針對纖維母細胞生長因子受體３（ｆｇｆｒ３）之化合物的療法
|
|
UA125496C2
(uk)
|
2015-06-08 |
2022-04-13 |
Дебіофарм Інтернаціонал, С.А. |
Спосіб лікування пацієнта з в-клітинним раком імунокон’югатом, який зв’язується з cd37 разом з антитілом, що зв'язується з cd20
|
|
WO2016203432A1
(en)
|
2015-06-17 |
2016-12-22 |
Novartis Ag |
Antibody drug conjugates
|
|
MD3313845T2
(ro)
|
2015-06-29 |
2021-02-28 |
Immunogen Inc |
Conjugați cu anticorpi având cisteină modificată prin inginerie genetică
|
|
CN116059395A
(zh)
|
2015-06-29 |
2023-05-05 |
第一三共株式会社 |
用于选择性制造抗体-药物缀合物的方法
|
|
SMT202000004T1
(it)
|
2015-07-21 |
2020-03-13 |
Immunogen Inc |
Metodi di preparazione dei derivati citotossici di benzodiazepina
|
|
EP3331569A1
(en)
|
2015-08-07 |
2018-06-13 |
Gamamabs Pharma |
Antibodies, antibody drug conjugates and methods of use
|
|
AU2016316758B2
(en)
|
2015-08-28 |
2023-02-02 |
Debiopharm International, S.A. |
Antibodies and assays for detection of CD37
|
|
JP6880006B2
(ja)
|
2015-09-17 |
2021-06-02 |
イミュノジェン， インコーポレイテッド |
抗ｆｏｌｒ１免疫複合体を含む治療組み合わせ
|
|
JP7628764B2
(ja)
|
2015-09-29 |
2025-02-12 |
アムジエン・インコーポレーテツド |
Ａｓｇｒ阻害剤
|
|
US20170189548A1
(en)
|
2015-11-25 |
2017-07-06 |
Immunogen, Inc. |
Pharmaceutical formulations and methods of use thereof
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
TWI852735B
(zh)
|
2015-12-04 |
2024-08-11 |
美商思進公司 |
四級胺化妥布賴森(tubulysin)化合物之結合物
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
BR112018075649A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
|
|
TWI762487B
(zh)
|
2016-06-08 |
2022-05-01 |
美商艾伯維有限公司 |
抗-b7-h3抗體及抗體藥物結合物
|
|
EP3468598A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
CA3027044A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
KR102590454B1
(ko)
|
2016-07-07 |
2023-10-17 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
항체-애쥬번트 접합체
|
|
MX2019001302A
(es)
|
2016-08-09 |
2019-06-12 |
Seattle Genetics Inc |
Conjugados de farmaco con enlazadores autoestabilizantes que tienen propiedades fisioquimicas mejoradas.
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CN109843334A
(zh)
|
2016-10-18 |
2019-06-04 |
西雅图基因公司 |
烟酰胺腺嘌呤二核苷酸补救途径抑制剂的靶向递送
|
|
WO2018083633A1
(en)
|
2016-11-02 |
2018-05-11 |
Debiopharm International, S.A. |
Methods for improving anti-cd37 immunoconjugate therapy
|
|
TWI755450B
(zh)
|
2016-11-23 |
2022-02-21 |
美商伊繆諾金公司 |
苯二氮平衍生物之選擇性磺化
|
|
EP3552626A4
(en)
|
2016-12-12 |
2020-06-10 |
Daiichi Sankyo Company, Limited |
ASSOCIATION OF AN ANTIBODY DRUG CONJUGATE AND AN IMMUNE CONTROL POINT INHIBITOR
|
|
JP7350313B2
(ja)
|
2016-12-16 |
2023-09-26 |
ブルーフィン バイオメディシン， インコーポレイテッド |
抗ｃｕｂドメイン含有タンパク質１（ｃｄｃｐ１）抗体、抗体薬物コンジュゲート、およびその使用方法
|
|
SI3558391T1
(sl)
|
2016-12-23 |
2022-06-30 |
Immunogen, Inc. |
Imunokonjugati, ciljno usmerjeni na ADAM9, in načini njihove uporabe
|
|
US20180230218A1
(en)
|
2017-01-04 |
2018-08-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
EP3572428A4
(en)
|
2017-01-17 |
2020-12-30 |
Daiichi Sankyo Company, Limited |
ANTI-BODY ANTI-GPR20 AND ANTI-BODY-DRUG CONJUGATE ANTI-GPR20
|
|
JOP20190187A1
(ar)
|
2017-02-03 |
2019-08-01 |
Novartis Ag |
مترافقات عقار جسم مضاد لـ ccr7
|
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CN116785450A
(zh)
|
2017-02-28 |
2023-09-22 |
伊缪诺金公司 |
具有自分解肽接头的类美登素衍生物和其缀合物
|
|
WO2018159582A1
(ja)
|
2017-02-28 |
2018-09-07 |
学校法人近畿大学 |
抗ｈｅｒ３抗体－薬物コンジュゲート投与によるｅｇｆｒ－ｔｋｉ抵抗性の非小細胞肺癌の治療方法
|
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
|
EP3612537B1
(en)
|
2017-04-18 |
2022-07-13 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
TW201839001A
(zh)
|
2017-04-20 |
2018-11-01 |
美商伊繆諾金公司 |
細胞毒性苯并二氮平衍生物及其綴合物
|
|
WO2018201087A1
(en)
|
2017-04-27 |
2018-11-01 |
Seattle Genetics, Inc. |
Quaternized nicotinamide adenine dinucleotide salvage pathway inhibitor conjugates
|
|
AR113224A1
(es)
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
Conjugados de anticuerpo que comprenden un agonista de sting
|
|
US11932650B2
(en)
|
2017-05-11 |
2024-03-19 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
TWI855528B
(zh)
|
2017-05-15 |
2024-09-11 |
日商第一三共股份有限公司 |
抗體-藥物結合物之製造方法
|
|
RS62928B1
(sr)
|
2017-08-18 |
2022-03-31 |
Medimmune Ltd |
Konjugati pirolobenzodiazepina
|
|
KR20250084239A
(ko)
|
2017-08-31 |
2025-06-10 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 콘주게이트의 개량 제조 방법
|
|
JP7248578B2
(ja)
|
2017-08-31 |
2023-03-29 |
第一三共株式会社 |
抗体－薬物コンジュゲートの新規製造方法
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
CN119857155A
(zh)
|
2017-11-29 |
2025-04-22 |
海德堡医药研究有限责任公司 |
用于耗尽cd5+细胞的组合物和方法
|
|
EP3732178A1
(en)
|
2017-12-28 |
2020-11-04 |
ImmunoGen, Inc. |
Benzodiazepine derivatives
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
US12060427B2
(en)
|
2018-03-28 |
2024-08-13 |
Mitsubishi Tanabe Pharma Corporat |
Drug conjugates of cMET monoclonal binding agents, and uses thereof
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
HRP20240756T1
(hr)
|
2018-05-18 |
2024-09-13 |
Daiichi Sankyo Co., Ltd. |
Anti-muc1-eksatekan antitijelo-lijek konjugat
|
|
CA3101790A1
(en)
|
2018-05-30 |
2019-12-05 |
Debiopharm International, S.A. |
Anti-cd37 immunoconjugate dosing regimens
|
|
MX2020013466A
(es)
|
2018-06-26 |
2021-04-19 |
Immunogen Inc |
Inmunoconjugados dirigidos a adam9 y métodos para usarlos.
|
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
CN112739340B
(zh)
|
2018-07-23 |
2025-05-13 |
海德堡医药研究有限责任公司 |
抗cd5抗体药物缀合物(adc)在同种异体细胞疗法中的用途
|
|
TWI846717B
(zh)
|
2018-07-27 |
2024-07-01 |
日商第一三共股份有限公司 |
辨識抗體-藥物結合物之藥物部位的蛋白質
|
|
EP3831412A4
(en)
|
2018-07-31 |
2022-04-27 |
Daiichi Sankyo Company, Limited |
TREATMENT OF METASTATIC BRAIN TUMOR BY ADMINISTRATION OF AN ANTIBODY-DRUG CONJUGATE
|
|
CN112912109A
(zh)
|
2018-09-20 |
2021-06-04 |
第一三共株式会社 |
通过施用抗her3抗体-药物缀合物治疗her3-突变的癌症
|
|
TWI897855B
(zh)
|
2018-10-26 |
2025-09-21 |
美商免疫遺傳股份有限公司 |
Ｅ ｐ Ｃ Ａ Ｍ 抗體、可活化抗體及免疫偶聯物以及其用途
|
|
WO2020089815A1
(en)
|
2018-10-31 |
2020-05-07 |
Novartis Ag |
Antibody conjugates comprising sting agonist
|
|
CN113348181A
(zh)
|
2018-10-31 |
2021-09-03 |
诺华股份有限公司 |
包含sting激动剂的dc-sign抗体缀合物
|
|
EP3891207B1
(en)
|
2018-12-04 |
2022-11-02 |
TIEN, Der-Yang |
Stereocomplexes for the delivery of anti-cancer agents
|
|
ES2967878T3
(es)
|
2019-03-15 |
2024-05-06 |
Medimmune Ltd |
Dímeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento del cáncer
|
|
JP2022525594A
(ja)
|
2019-03-15 |
2022-05-18 |
ボルト バイオセラピューティクス、インコーポレーテッド |
Ｈｅｒ２を標的とする免疫結合体
|
|
SG11202109986TA
(en)
|
2019-03-20 |
2021-10-28 |
Univ California |
Claudin-6 antibodies and drug conjugates
|
|
WO2020191344A1
(en)
|
2019-03-20 |
2020-09-24 |
The Regents Of The University Of California |
Claudin-6 bispecific antibodies
|
|
EP3947395A1
(en)
|
2019-03-29 |
2022-02-09 |
ImmunoGen, Inc. |
Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhibiting abnormal cell growth or for treating proliferative diseases
|
|
CR20210541A
(es)
|
2019-03-29 |
2021-12-20 |
Medimmune Ltd |
Compuestos y conjugados de estos
|
|
HUE065484T2
(hu)
|
2019-04-26 |
2024-05-28 |
Immunogen Inc |
Camptothecin-származékok
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
JP7407845B2
(ja)
*
|
2019-06-28 |
2024-01-04 |
シャンハイ フダン－チャンジャン バイオ－ファーマシューティカル カンパニー リミテッド |
抗体薬物複合体、その中間体、製造方法及び使用
|
|
AU2020364071A1
(en)
|
2019-10-10 |
2022-05-26 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
CN111116904A
(zh)
*
|
2019-11-14 |
2020-05-08 |
华东师范大学 |
一种含苯硼酸修饰的含氟高分子材料及其在蛋白质胞内递送中的应用
|
|
JP6949343B1
(ja)
|
2019-12-18 |
2021-10-13 |
国立大学法人 岡山大学 |
抗体薬物コンジュゲート及び抗体の薬物送達のための使用
|
|
CN111039981B
(zh)
*
|
2019-12-26 |
2022-10-04 |
上海科技大学 |
一种化合物、及其盐或溶剂合物及其应用
|
|
BR112022017064A2
(pt)
|
2020-02-25 |
2022-11-16 |
Mediboston Inc |
Derivados da camptotecina e seus conjugados
|
|
US20230181756A1
(en)
|
2020-04-30 |
2023-06-15 |
Novartis Ag |
Ccr7 antibody drug conjugates for treating cancer
|
|
US20230256114A1
(en)
|
2020-07-07 |
2023-08-17 |
Bionecure Therapeutics, Inc. |
Novel maytansinoids as adc payloads and their use for the treatment of cancer
|
|
US20230277679A1
(en)
|
2020-07-17 |
2023-09-07 |
Daiichi Sankyo Company, Limited |
Method for producing antibody-drug conjugate
|
|
ES2963150T3
(es)
|
2020-10-27 |
2024-03-25 |
Elucida Oncology Inc |
Procedimientos para funcionalizar nanopartículas
|
|
US12564642B2
(en)
|
2020-11-10 |
2026-03-03 |
Sanofi |
CEACAM5 antibody-drug conjugate formulation
|
|
CR20230283A
(es)
|
2020-11-24 |
2023-07-27 |
Novartis Ag |
Anticuerpos anti-cd48, conjugados de anticuerpo-fármaco, y usos de los mismos
|
|
AR124475A1
(es)
|
2020-12-23 |
2023-03-29 |
Univ Muenchen Ludwig Maximilians |
Conjugados anticuerpo-droga mejorados dirigidos contra cd30 y usos de los mismos
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US12030888B2
(en)
|
2021-02-24 |
2024-07-09 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US12521444B2
(en)
|
2021-02-25 |
2026-01-13 |
Fortvita Biologics Limited |
Anti-HER2 antibody-drug conjugates and uses thereof
|
|
WO2023083900A1
(en)
|
2021-11-09 |
2023-05-19 |
Tubulis Gmbh |
Conjugates comprising a phosphorus (v) and a drug moiety
|
|
EP4429709A1
(en)
|
2021-11-09 |
2024-09-18 |
Tubulis GmbH |
Conjugates comprising a phosphorus (v) and a camptothecin moiety
|
|
WO2023157989A1
(ko)
|
2022-02-17 |
2023-08-24 |
주식회사 노벨티노빌리티 |
항체-약물 접합체
|
|
JP2025524986A
(ja)
|
2022-07-27 |
2025-08-01 |
メディボストン リミテッド |
オーリスタチン誘導体およびそのコンジュゲート
|
|
CN120112312A
(zh)
|
2022-10-18 |
2025-06-06 |
Tubulis 股份有限公司 |
新型抗-tpbg抗体和基于其的抗体-药物偶联物、其治疗方法及用途
|
|
CN120112313A
(zh)
|
2022-10-18 |
2025-06-06 |
Tubulis 股份有限公司 |
具有新型napi2b抗体的新型抗体药物偶联物、其治疗方法和用途
|
|
WO2024121632A1
(en)
|
2022-12-09 |
2024-06-13 |
Crispr Therapeutics Ag |
Use of anti-cd117 antibody drug conjugate (adc)
|
|
IL322569A
(en)
|
2023-02-09 |
2025-10-01 |
Beone Medicines I Gmbh |
Self-stabilizing bonding material bracelets
|
|
TW202438114A
(zh)
|
2023-03-23 |
2024-10-01 |
瑞士商百濟神州瑞士有限責任公司 |
生物活性結合物、其製備方法及其用途
|
|
CN121219016A
(zh)
|
2023-06-02 |
2025-12-26 |
第一三共株式会社 |
抗-her3抗体-药物缀合物和rasg12c抑制剂的组合
|
|
WO2025019790A1
(en)
|
2023-07-19 |
2025-01-23 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with trop-2 targeting adc
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
WO2025094146A1
(en)
|
2023-11-02 |
2025-05-08 |
Immunogen Switzerland Gmbh |
Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
|
|
WO2025126157A1
(en)
|
2023-12-15 |
2025-06-19 |
Advesya |
Anti-il-1rap binding domains and antibody-drug conjugates thereof
|
|
WO2025186213A1
(en)
|
2024-03-04 |
2025-09-12 |
Debiopharm International S.A. |
Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor
|